The JAK2 46/1 haplotype confers susceptibility to essential thrombocythemia regardless of JAK2V617F mutational statusclinical correlates in a study of 226 consecutive patients

A. Pardanani, T. L. Lasho, C. M. Finke, N. Gangat, A. P. Wolanskyj, C. A. Hanson, A. Tefferi

Research output: Contribution to journal › Article › peer-review

54 Scopus citations

Fingerprint

Dive into the research topics of 'The JAK2 46/1 haplotype confers susceptibility to essential thrombocythemia regardless of JAK2V617F mutational statusclinical correlates in a study of 226 consecutive patients'. Together they form a unique fingerprint.

Medicine & Life Sciences